Skip to content

Risks and Benefits of ADHD Medication for Suicidal Behavior: A National Study of At-Risk Youth

2020 Distinguished Investigator Grant
Amount Awarded: $124,984
Focus Areas: Psychosocial Studies, Clinical Treatment Studies

Brian D'Onofrio, Ph.D.

Brian D'Onofrio, Ph.D.
Indiana University

Inside the Research

Individuals with attention-deficit/hyperactivity disorder (ADHD) are at increased risk for suicide and more youth with ADHD are being treated with medication. Medicaid healthcare claim data will be used to explore the benefits and/or risks of ADHD medication for suicidal behavior. Findings can inform medical practice about youth at high-risk for suicidal behavior, especially for those with psychiatric conditions, in underrepresented racial and ethnic groups, in rural communities, and in foster care.